UK Direct-to-consumer Genetic Testing Market Size & Outlook
Related Markets
UK direct-to-consumer genetic testing market highlights
- The UK direct-to-consumer genetic testing market generated a revenue of USD 110.1 million in 2023 and is expected to reach USD 666.4 million by 2030.
- The UK market is expected to grow at a CAGR of 29.3% from 2024 to 2030.
- In terms of segment, predictive testing was the largest revenue generating test type in 2023.
- Predictive Testing is the most lucrative test type segment registering the fastest growth during the forecast period.
Direct-to-consumer genetic testing market data book summary
| Market revenue in 2023 | USD 110.1 million |
| Market revenue in 2030 | USD 666.4 million |
| Growth rate | 29.3% (CAGR from 2023 to 2030) |
| Largest segment | Predictive testing |
| Fastest growing segment | Predictive Testing |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Nutrigenomics Testing, Predictive Testing, Carrier Testing, Other Test Types |
| Key market players worldwide | 23andMe Holding Co Class A, Genesis Healthcare Inc Class A, Bureau Veritas SA, Myriad Genetics Inc, Color, Living DNA, Full Genomes, EasyDNA, Ancestry, Family Tree DNA, Nanobiomatters Industries, Milliken & Company, Biocote, Microban International, SteriTouch, Sanitized |
Other key industry trends
- In terms of revenue, UK accounted for 5.7% of the global direct-to-consumer genetic testing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK direct-to-consumer genetic testing market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 666.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Direct-to-Consumer Genetic Testing Market Scope
Direct-to-Consumer Genetic Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Sanitized | View profile | 101-250 | Burgdorf, Bern, Switzerland, Europe | https://www.sanitized.com |
| SteriTouch | View profile | 11-50 | Ebbw Vale, Blaenau Gwent, United Kingdom, Europe | http://www.steritouch.com |
| Microban International | View profile | 51-100 | Huntersville, North Carolina, United States, North America | http://www.microban.com/en-uk |
| Biocote | View profile | 11-50 | Coventry, Coventry, United Kingdom, Europe | https://www.biocote.com |
| Milliken & Company | View profile | 501-1000 | Spartanburg, South Carolina, United States, North America | http://www.milliken.com/en-us/ |
| Nanobiomatters Industries | View profile | 11-50 | Paterna De Rivera, Andalucia, Spain, Europe | http://www.nanobiomatters.com |
| Family Tree DNA | View profile | 11-50 | Houston, Texas, United States, North America | https://www.familytreedna.com/ |
| Ancestry | View profile | - | Melbourne, Victoria, Australia, Oceania | https://www.ancestry.com.au/ |
| EasyDNA | View profile | 11-50 | Grove City, Ohio, United States, North America | https://www.easy-dna.com |
| Full Genomes | View profile | 1-10 | Rockville, Maryland, United States, North America | http://fullgenomes.com |
| Living DNA | View profile | 1-10 | Bridgwater, Somerset, United Kingdom, Europe | https://livingdna.com/ |
| Color | View profile | 501-1000 | Burlingame, California, United States, North America | https://www.color.com |
| Bureau Veritas SA | View profile | 81511 | 40/52 Boulevard du Parc, Immeuble Newtime, Neuilly-sur-Seine, France, 92200 | https://group.bureauveritas.com |
| 23andMe Holding Co Class A | View profile | 816 | 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 | https://www.23andme.com |
| Myriad Genetics Inc | View profile | 2700 | 320 Wakara Way, Salt Lake City, UT, United States, 84108 | https://www.myriad.com |
| Genesis Healthcare Inc Class A | View profile | 44000 | 101 East State Street, Kennett Square, PA, United States, 19348 | http://www.genesishcc.com |
UK direct-to-consumer genetic testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to direct-to-consumer genetic testing market will help companies and investors design strategic landscapes.
Predictive testing was the largest segment with a revenue share of 38.06% in 2023. Horizon Databook has segmented the UK direct-to-consumer genetic testing market based on nutrigenomics testing, predictive testing, carrier testing, other test types covering the revenue growth of each sub-segment from 2018 to 2030.
- UK Direct-to-Consumer Genetic Testing Test Type Outlook (Revenue, USD Million, 2018-2030)
- Nutrigenomics Testing
- Predictive Testing
- Carrier Testing
- Other Test Types
- UK Direct-to-Consumer Genetic Testing Technology Outlook (Revenue, USD Million, 2018-2030)
- Targeted Analysis
- Single Nucleotide Polymorphism Chips
- Whole Genome Sequencing
- Other Technologies
- UK Direct-to-Consumer Genetic Testing Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Online Platform
- OTC
Reasons to subscribe to UK direct-to-consumer genetic testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK direct-to-consumer genetic testing market databook
-
Our clientele includes a mix of direct-to-consumer genetic testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK direct-to-consumer genetic testing market , including forecasts for subscribers. This country databook contains high-level insights into UK direct-to-consumer genetic testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK direct to consumer genetic testing market size, by technology, 2018-2030 (US$M)
UK Direct-to-Consumer Genetic Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
